- call +1-201-465-4211
- email sales@mrinsights.biz
Drug of abuse testing is based on diagnosing drug addiction, also called substance use disorder, requiring a thorough evaluation and often includes an assessment by a psychiatrist, a psychologist, or a licensed alcohol and drug counselor. Blood, urine or other lab tests are used to assess drug use, but they're not a diagnostic test for addiction. These tests may be used for monitoring treatment.
Scope of the Report:
This report studies the Drug of Abuse Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Drug of Abuse Testing market by product type and applications/end industries.
The factor which may influence the growth of the drug of abuse testing market is increased use of drug testing at organizational level, increased production and trade of illicit drugs worldwide and others. Globally the market for drug of abuse testing is expected to grow at 5.8% GAGR from 2017 to 2025.
The global Drug of Abuse Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Drug of Abuse Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Roche Holding
Quest Diagnostics
Alere
Abbott Laboratories
Randox Laboratories
Psychemedics Corporation
Bio-Rad Laboratories
Sonic Healthcare
Thermo Fisher Scientific
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Onsite Screening Test
Laboratory Drug Testing
Market Segment by Applications, can be divided into
Healthcare
Laboratory
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Drug of Abuse Testing Market Overview
1.1 Product Overview and Scope of Drug of Abuse Testing
1.2 Classification of Drug of Abuse Testing by Types
1.2.1 Global Drug of Abuse Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Drug of Abuse Testing Revenue Market Share by Types in 2017
1.2.3 Onsite Screening Test
1.2.4 Laboratory Drug Testing
1.3 Global Drug of Abuse Testing Market by Application
1.3.1 Global Drug of Abuse Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Healthcare
1.3.3 Laboratory
1.4 Global Drug of Abuse Testing Market by Regions
1.4.1 Global Drug of Abuse Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Drug of Abuse Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Drug of Abuse Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drug of Abuse Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Drug of Abuse Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drug of Abuse Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Drug of Abuse Testing (2013-2023)
2 Manufacturers Profiles
2.1 Roche Holding
2.1.1 Business Overview
2.1.2 Drug of Abuse Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Holding Drug of Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Quest Diagnostics
2.2.1 Business Overview
2.2.2 Drug of Abuse Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Quest Diagnostics Drug of Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Alere
2.3.1 Business Overview
2.3.2 Drug of Abuse Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Alere Drug of Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Abbott Laboratories
2.4.1 Business Overview
2.4.2 Drug of Abuse Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Laboratories Drug of Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Randox Laboratories
2.5.1 Business Overview
2.5.2 Drug of Abuse Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Randox Laboratories Drug of Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Psychemedics Corporation
2.6.1 Business Overview
2.6.2 Drug of Abuse Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Psychemedics Corporation Drug of Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bio-Rad Laboratories
2.7.1 Business Overview
2.7.2 Drug of Abuse Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bio-Rad Laboratories Drug of Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sonic Healthcare
2.8.1 Business Overview
2.8.2 Drug of Abuse Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sonic Healthcare Drug of Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Thermo Fisher Scientific
2.9.1 Business Overview
2.9.2 Drug of Abuse Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Thermo Fisher Scientific Drug of Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Drug of Abuse Testing Market Competition, by Players
3.1 Global Drug of Abuse Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Drug of Abuse Testing Players Market Share
3.2.2 Top 10 Drug of Abuse Testing Players Market Share
3.3 Market Competition Trend
4 Global Drug of Abuse Testing Market Size by Regions
4.1 Global Drug of Abuse Testing Revenue and Market Share by Regions
4.2 North America Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
4.5 South America Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
5 North America Drug of Abuse Testing Revenue by Countries
5.1 North America Drug of Abuse Testing Revenue by Countries (2013-2018)
5.2 USA Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
6 Europe Drug of Abuse Testing Revenue by Countries
6.1 Europe Drug of Abuse Testing Revenue by Countries (2013-2018)
6.2 Germany Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
6.3 UK Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
6.4 France Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Drug of Abuse Testing Revenue by Countries
7.1 Asia-Pacific Drug of Abuse Testing Revenue by Countries (2013-2018)
7.2 China Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
7.5 India Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
8 South America Drug of Abuse Testing Revenue by Countries
8.1 South America Drug of Abuse Testing Revenue by Countries (2013-2018)
8.2 Brazil Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Drug of Abuse Testing by Countries
9.1 Middle East and Africa Drug of Abuse Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Drug of Abuse Testing Revenue and Growth Rate (2013-2018)
10 Global Drug of Abuse Testing Market Segment by Type
10.1 Global Drug of Abuse Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Drug of Abuse Testing Market Forecast by Type (2018-2023)
10.3 Onsite Screening Test Revenue Growth Rate (2013-2023)
10.4 Laboratory Drug Testing Revenue Growth Rate (2013-2023)
11 Global Drug of Abuse Testing Market Segment by Application
11.1 Global Drug of Abuse Testing Revenue Market Share by Application (2013-2018)
11.2 Drug of Abuse Testing Market Forecast by Application (2018-2023)
11.3 Healthcare Revenue Growth (2013-2018)
11.4 Laboratory Revenue Growth (2013-2018)
12 Global Drug of Abuse Testing Market Size Forecast (2018-2023)
12.1 Global Drug of Abuse Testing Market Size Forecast (2018-2023)
12.2 Global Drug of Abuse Testing Market Forecast by Regions (2018-2023)
12.3 North America Drug of Abuse Testing Revenue Market Forecast (2018-2023)
12.4 Europe Drug of Abuse Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Drug of Abuse Testing Revenue Market Forecast (2018-2023)
12.6 South America Drug of Abuse Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Drug of Abuse Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Drug of Abuse Testing Picture
Table Product Specifications of Drug of Abuse Testing
Table Global Drug of Abuse Testing and Revenue (Million USD) Market Split by Prod
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
